Primary care Osteoarthritis Screening Trial (POST): a cluster randomised trial of an electronic prompt for comorbidity screening in clinical osteoarthritis consultations in primary care
ISRCTN | ISRCTN40721988 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN40721988 |
Secondary identifying numbers | 10334 |
- Submission date
- 21/06/2011
- Registration date
- 21/06/2011
- Last edited
- 23/07/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Jacqueline Gray
Scientific
Scientific
Arthritis Research UK Primary Care Centre
Primary Care Sciences
Keele University
Newcastle under Lyme
ST5 5BG
United Kingdom
Study information
Study design | Randomised; Interventional; Design type: Screening |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Screening |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | Primary care Osteoarthritis Screening Trial (POST): a cluster randomised trial of an electronic prompt for comorbidity screening in clinical osteoarthritis consultations in primary care |
Study acronym | POST |
Study objectives | POST is a cluster randomised clinical trial that will compare pain intensity and interference outcomes over a 12-month period in osteoarthritis (OA)/joint pain patients screened for depression and anxiety (intervention arm) to those who receive usual care (control arm; screened only for pain intensity). As a cluster randomised trial the GP practices will be randomised (to one of the 2 arms) rather than the patients. We aim to recruit 44 GP practices in total in order to screen and contact 1745 patients. Recruitment of patients from GP practices will take place over 12 months. It is anticipated that patients will be contacted within 1-2 weeks of their index consultation with a baseline questionnaire and those who consent will be followed-up with further postal questionnaires 3, 6 and 12 months following their baseline. These questionnaires contain detailed questions on pain intensity and interference (our primary outcomes) and further questions on anxiety, depression, pain catastrophising, health economics and demographics. A medical record review of treatments, diagnoses and referrals will be conducted for patients who consent |
Ethics approval(s) | 11/WM/0093; First MREC approval date 04/04/2011 |
Health condition(s) or problem(s) studied | Osteoarthritis |
Intervention | Generalised Anxiety Disorder-2 (GAD-2) 1. Eligible patients in the intervention arm consulting their GP for osteoarthritis or joint pain will be asked these 4 questions on depressive and anxiety symptoms during their consultation: 1.1. Modified Patient Hlth Quest 1.2. Modified Patient Health Questionnaire (PHQ-2) 2. Eligible patients in the intervention arm consulting their GP for osteoarthritis or joint pain will be asked these 4 questions on depressive and anxiety symptoms during their consultation 3. Follow-up length: 12 months |
Intervention type | Other |
Primary outcome measure | 1. Self report measure of current pain intensity measured at baseline, 3 months, 6 months and 12 months |
Secondary outcome measures | 1. Anxiety (GAD-7 (5)) at baseline, 3 months, 6 months and 12 months 2. Body mass index (from self reported height and weight) at baseline, 3 months, 6 months and 12 months 3. Characteristic Pain Intensity and Disability Score at baseline, 3 months, 6 months and 12 months 4. Demographics (marital status and occupation/employment details) at baseline, 3 months, 6 months and 12 months 5. Depression (PHQ-8 (4)) at baseline, 3 months, 6 months and 12 months 6. Detailed questions about pain at baseline, 3 months, 6 months and 12 months 7. Medication and health care use at baseline, 3 months, 6 months and 12 months 8. Overall quality of life (EQ5D (2) and SF-36 (3)) at baseline, 3 months, 6 months and 12 months 9. Pain Catastrophising Scale (6) at baseline, 3 months, 6 months and 12 months 10. Pain interference with daily activities at baseline, 3 months, 6 months and 12 months 11. Social support (questions taken from previous postal surveys) at baseline, 3 months, 6 months and 12 months |
Overall study start date | 29/07/2011 |
Completion date | 30/09/2012 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | Planned Sample Size: 1309; UK Sample Size: 1309 |
Key inclusion criteria | 1. Aged 45 years and over 2. Registered with the participating GP practices during the specified study period of that practice 3. Read-coded peripheral joint pain or OA consultation within the specified study period (termed the index consultation) 4. May be first, new episode, or ongoing consultation) 5. Provided full written informed consent to study participation and to further contact 6. Male & female |
Key exclusion criteria | 1. Patients who are under active care for or who have a diagnosis of depression and/or an anxiety disorder in the past 12 months 2. Vulnerable patients, including any patients on the Quality and Outcomes Framework mental health register, or those who have a diagnosis of dementia or a terminal illness 3. Patients who reside in a nursing home 4. Red flag pathology 5. Recent trauma associated with significant injury 6. Acute, red, hot swollen joint 7. Inflammatory arthropathy, crystal disease, spondyloarthropathy and polymyalgia rheumatic |
Date of first enrolment | 29/07/2011 |
Date of final enrolment | 30/09/2012 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Keele University
Newcastle under Lyme
ST5 5BG
United Kingdom
ST5 5BG
United Kingdom
Sponsor information
Keele University
University/education
University/education
Keele
Newcastle under Lyme
ST5 5BG
England
United Kingdom
Website | http://www.keele.ac.uk/ |
---|---|
https://ror.org/00340yn33 |
Funders
Funder type
Government
National Institute for Health Research, ref: RP-PG-0407-10386 (United Kingdom)
Government organisation / National government
Government organisation / National government
- Alternative name(s)
- National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 11/04/2017 | Yes | No | |
Results article | results | 01/07/2018 | Yes | No | |
Other publications | cost-utility analysis | 01/12/2018 | 23/07/2019 | Yes | No |
Editorial Notes
23/07/2019: Publication reference added.
27/07/2018: Publication reference added.
12/04/2017: Publication reference added.